Diagnosis, Classification, and Evaluation of Chronic Kidney Disease
By:
Teresa K. Chen Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Search for other papers by Teresa K. Chen in
Current site
Google Scholar
PubMed Close
and
Morgan E. Grams Department of Medicine, New York University Langone School of Medicine, New York, New York

Search for other papers by Morgan E. Grams in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 21: Issue 2
Published Online:
Jun 2022
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand
Cover Nephrology Self-Assessment Program
Copyright:
Copyright © 2022 by the American Society of Nephrology 2022
Page Count:
11
Article Category:
Research Article
Print Publication Date:
01 Jun 2022
Published Online:
Jun 2022
  • 1

    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Available at: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Accessed July 7, 2021

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    United States Renal Data System: 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2020

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Chen TK, Knicely DH, Grams ME: Chronic kidney disease diagnosis and management: A review. JAMA 322: 1294–1304, 2019 PubMed

  • 4

    Chu CD, McCulloch CE, Banerjee T, Pavkov ME, Burrows NR, Gillespie BW, et al.; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team: CKD awareness among US adults by future risk of kidney failure. Am J Kidney Dis 76: 174–183, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al.: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension 71: e13–e115, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al.; Conference Participants: The case for early identification and intervention of chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference Available at: https://kdigo.org/wp-content/uploads/2019/01/KDIGO-Early-CKD-ID-and-intervention-conf-report-FINAL.pdf. Accessed April 12, 2021

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Peralta CA, Frigaard M, Rolon L, Seal K, Tuot D, Senyak J, et al.: Screening for CKD to improve processes of care among nondiabetic veterans with hypertension: A pragmatic cluster-randomized trial. Clin J Am Soc Nephrol 15: 174–181, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Burrows NR, Vassalotti JA, Saydah SH, Stewart R, Gannon M, Chen SC, et al.: Identifying high-risk individuals for chronic kidney disease: Results of the CHERISH community demonstration project. Am J Nephrol 48: 447–455, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Stempniewicz N, Vassalotti JA, Cuddeback JK, Ciemins E, Storfer-Isser A, Sang Y, et al.: Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. health care organizations. Diabetes Care 44: 2000–2009, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Shin JI, Chang AR, Grams ME, Coresh J, Ballew SH, Surapaneni A, et al.; CKD Prognosis Consortium: Albuminuria testing in hypertension and diabetes: An individual-participant data meta-analysis in a global consortium. Hypertension 78: 1042–1052, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    American Diabetes Association: 11. Microvascular complications and foot care: Standards of medical care in diabetes-2021. Diabetes Care 44[Suppl 1]: S151–S167, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al.; ESC Scientific Document Group: 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41: 255–323, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Qiao Y, Shin JI, Chen TK, Sang Y, Coresh J, Vassalotti JA, et al.: Association of albuminuria levels with the prescription of renin-angiotensin system blockade. Hypertension 76: 1762–1768, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Umeukeje EM, Wild MG, Maripuri S, Davidson T, Rutherford M, Abdel-Kader K, et al.: Black Americans’ perspectives of barriers and facilitators of community screening for kidney disease. Clin J Am Soc Nephrol 13: 551–559, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461–470, 1999 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Powe NR: Black kidney function matters: Use or misuse of race? JAMA 324: 737–738, 2020 PubMed

  • 18

    Delgado C, Baweja M, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, et al.: A unifying approach for GFR estimation: Recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol 32: 2994–3015, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al.; Chronic Kidney Disease Epidemiology Collaboration: New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385: 1737–1749, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Inker LA, Titan S: Measurement and estimation of GFR for use in clinical practice: Core curriculum 2021. Am J Kidney Dis 78: 736–749, 2021 PubMed

  • 21

    Hsu CY, Yang W, Parikh RV, Anderson AH, Chen TK, Cohen DL, et al.; CRIC Study Investigators: Race, genetic ancestry, and estimating kidney function in CKD. N Engl J Med 385: 1750–1760, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al.; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20–29, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Inker LA, Couture SJ, Tighiouart H, Abraham AG, Beck GJ, Feldman HI, et al.; CKD-EPI GFR Collaborators: A new panel-estimated GFR, including β2-microglobulin and β-trace protein and not including race, developed in a diverse population. Am J Kidney Dis 77: 673–683.e1, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Coresh J, Inker LA, Sang Y, Chen J, Shafi T, Post WS, et al.: Metabolomic profiling to improve glomerular filtration rate estimation: A proof-of-concept study. Nephrol Dial Transplant 34: 825–833, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, et al.; Chronic Kidney Disease Prognosis Consortium: Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis : An individual participant-based meta-analysis. Ann Intern Med 173: 426–435, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Weaver RG, James MT, Ravani P, Weaver CGW, Lamb EJ, Tonelli M, et al.: Estimating urine albumin-to-creatinine ratio from protein-to-creatinine ratio: Development of equations using same-day measurements. J Am Soc Nephrol 31: 591–601, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Naranjo FSSY, Sang Y, Ballew SH, Stempniewicz N, Dunning SC, Levey AS, et al.: Estimating kidney failure risk using electronic medical records. Kidney360 2: 415–424, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al.: The definition, classification, and prognosis of chronic kidney disease: A KDIGO controversies conference report. Kidney Int 80: 17–28, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, et al.: Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: The CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 72: 653–661, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, et al.: Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 17: 2582–2590, 2006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al.: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553–1559, 2011 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al.; CKD Prognosis Consortium: Multinational assessment of accuracy of equations for predicting risk of kidney failure: A meta-analysis. JAMA 315: 164–174, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, et al.: Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93: 1442–1451, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, et al.; CKD Prognosis Consortium: Development of risk prediction equations for incident chronic kidney disease. JAMA 322: 2104–2114, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Ramspek CL, Evans M, Wanner C, Drechsler C, Chesnaye NC, Szymczak M, et al.; EQUAL Study Investigators: Kidney failure prediction models: A comprehensive external validation study in patients with advanced CKD. J Am Soc Nephrol 32: 1174–1186, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, et al.: The prognostic value of histopathologic lesions in native kidney biopsy specimens: Results from the Boston Kidney Biopsy Cohort study. J Am Soc Nephrol 29: 2213–2224, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, et al.: Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Nephrol Dial Transplant 33: 310–318, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Royal V, Zee J, Liu Q, Avila-Casado C, Smith AR, Liu G, et al.: Ultrastructural characterization of proteinuric patients predicts clinical outcomes. J Am Soc Nephrol 31: 841–854, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Palmer MB, Abedini A, Jackson C, Blady S, Chatterjee S, Sullivan KM, et al.: The role of glomerular epithelial injury in kidney function decline in patients with diabetic kidney disease in the TRIDENT cohort. Kidney Int Rep 6: 1066–1080, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Charlton JR, Xu Y, Wu T, deRonde KA, Hughes JL, Dutta S, et al.: Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease. Kidney Int 99: 173–185, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Srivastava A, Cai X, Lee J, Li W, Larive B, Kendrick C, et al.: Kidney functional magnetic resonance imaging and change in eGFR in individuals with CKD. Clin J Am Soc Nephrol 15: 776–783, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Sun Q, Baues M, Klinkhammer BM, Ehling J, Djudjaj S, Drude NI, et al.: Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis. Sci Transl Med 11: eaat4865, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Koratala A, Bhattacharya D, Kazory A: Point of care renal ultrasonography for the busy nephrologist: A pictorial review. World J Nephrol 8: 44–58, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Koratala A, Teodorescu V, Niyyar VD: The nephrologist as an ultrasonographer. Adv Chronic Kidney Dis 27: 243–252, 2020 PubMed

  • 45

    Koratala A, Segal MS, Kazory A: Integrating point-of-care ultrasonography into nephrology fellowship training: A model curriculum. Am J Kidney Dis 74: 1–5, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Mullangi S, Sozio SM, Hellmann DB, Martire C, Lohani S, Segal P, et al.: Integrative point-of-care ultrasound curriculum to impart diagnostic skills relevant to nephrology. Am J Kidney Dis 73: 894–896, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47

    Cavanaugh C, Perazella MA: Urine sediment examination in the diagnosis and management of kidney disease: Core curriculum 2019. Am J Kidney Dis 73: 258–272, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48

    Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, et al.: Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23: 516–524, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49

    Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al.: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23: 507–515, 2012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50

    Coca SG, Nadkarni GN, Huang Y, Moledina DG, Rao V, Zhang J, et al.: Plasma biomarkers and kidney function decline in early and established diabetic kidney disease. J Am Soc Nephrol 28: 2786–2793, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Schrauben SJ, Shou H, Zhang X, Anderson AH, Bonventre JV, Chen J, et al.; CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study. J Am Soc Nephrol 32: 115–126, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52

    Chen TK, Estrella MM, Appel LJ, Coresh J, Luo S, Reiser J, et al.: Biomarkers of immune activation and incident kidney failure with replacement therapy: Findings from the African American study of kidney disease and hypertension. Am J Kidney Dis 78: 75–84.e1, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53

    Chen TK, Coca SG, Estrella MM, Appel LJ, Coresh J, Thiessen Philbrook H, et al.; CKD Biomarkers Consortium (BioCon): Longitudinal TNFR1 and TNFR2 and kidney outcomes: Results from AASK and VA NEPHRON-D. J Am Soc Nephrol 33: 996–1010, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54

    Greenberg JH, Abraham AG, Xu Y, Schelling JR, Feldman HI, Sabbisetti VS, et al.; CKD Biomarkers Consortium: Plasma biomarkers of tubular injury and inflammation are associated with CKD progression in children. J Am Soc Nephrol 31: 1067–1077, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55

    Gutiérrez OM, Shlipak MG, Katz R, Waikar SS, Greenberg JH, Schrauben SJ, et al.: Associations of plasma biomarkers of inflammation, fibrosis, and kidney tubular injury with progression of diabetic kidney disease: A cohort study. Am J Kidney Dis 79: 849–857, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56

    Bhatraju PK, Zelnick LR, Shlipak M, Katz R, Kestenbaum B: Association of soluble TNFR-1 concentrations with long-term decline in kidney function: The multi-ethnic study of atherosclerosis. J Am Soc Nephrol 29: 2713–2721, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57

    Sen T, Li J, Neuen BL, Neal B, Arnott C, Parikh CR, et al.: Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial. Diabetologia 64: 2147–2158, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58

    Hayek SS, Sever S, Ko YA, Trachtman H, Awad M, Wadhwani S, et al.: Soluble urokinase receptor and chronic kidney disease. N Engl J Med 373: 1916–1925, 2015 PubMed

  • 59

    Luo S, Coresh J, Tin A, Rebholz CM, Chen TK, Hayek SS, et al.: Soluble urokinase-type plasminogen activator receptor in Black Americans with CKD. Clin J Am Soc Nephrol 13: 1013–1021, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60

    Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al.: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11–21, 2009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61

    Sethi S: New “antigens” in membranous nephropathy. J Am Soc Nephrol 32: 268–278, 2021 PubMed

  • 62

    Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, et al.: Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int 95: 429–438, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63

    Burbelo PD, Joshi M, Chaturvedi A, Little DJ, Thurlow JS, Waldman M, et al.: Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J Am Soc Nephrol 31: 208–217, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 64

    Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al.: Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371: 2277–2287, 2014 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65

    Cavanaugh C, Okusa MD: The evolving role of novel biomarkers in glomerular disease: A review. Am J Kidney Dis 77: 122–131, 2021 PubMed

  • 66

    Ren S, Wu C, Zhang Y, Wang AY, Li G, Wang L, et al.: An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: A systematic review and meta-analysis of THSD7A in IMN. Ren Fail 40: 306–313, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67

    Tomas NM, Hoxha E, Reinicke AT, Fester L, Helmchen U, Gerth J, et al.: Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. J Clin Invest 126: 2519–2532, 2016 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68

    Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, et al.: Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30: 1123–1136, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69

    Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross L, et al.: Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 97: 163–174, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70

    Sethi S, Debiec H, Madden B, Vivarelli M, Charlesworth MC, Ravindran A, et al.: Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int 98: 1253–1264, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 71

    Sethi S, Madden B, Debiec H, Morelle J, Charlesworth MC, Gross L, et al.: Protocadherin 7-associated membranous nephropathy. J Am Soc Nephrol 32: 1249–1261, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72

    Cocchi E, Nestor JG, Gharavi AG: Clinical genetic screening in adult patients with kidney disease. Clin J Am Soc Nephrol 15: 1497–1510, 2020 PubMed

  • 73

    Lata S, Marasa M, Li Y, Fasel DA, Groopman E, Jobanputra V, et al.: Whole-exome sequencing in adults with chronic kidney disease: A pilot study. Ann Intern Med 168: 100–109, 2018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74

    Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al.: Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 380: 142–151, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 75

    Ottlewski I, Münch J, Wagner T, Schönauer R, Bachmann A, Weimann A, et al.: Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int 96: 222–230, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76

    Mann N, Braun DA, Amann K, Tan W, Shril S, Connaughton DM, et al.: Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients. J Am Soc Nephrol 30: 201–215, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77

    Connaughton DM, Kennedy C, Shril S, Mann N, Murray SL, Williams PA, et al.: Monogenic causes of chronic kidney disease in adults. Kidney Int 95: 914–928, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78

    Rao J, Liu X, Mao J, Tang X, Shen Q, Li G, et al.; for “Internet Plus” Nephrology Alliance of National Center for Children’s Care: Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system. Clin Genet 96: 402–410, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79

    Hays T, Groopman EE, Gharavi AG: Genetic testing for kidney disease of unknown etiology. Kidney Int 98: 590–600, 2020 PubMed

  • 80

    Yao T, Udwan K, John R, Rana A, Haghighi A, Xu L, et al.: Integration of genetic testing and pathology for the diagnosis of adults with FSGS. Clin J Am Soc Nephrol 14: 213–223, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81

    Rasouly HM, Groopman EE, Heyman-Kantor R, Fasel DA, Mitrotti A, Westland R, et al.: The burden of candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequencing. Ann Intern Med 170: 11–21, 2019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82

    Xie J, Liu L, Mladkova N, Li Y, Ren H, Wang W, et al.: The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat Commun 11: 1600, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83

    Schönauer R, Baatz S, Nemitz-Kliemchen M, Frank V, Petzold F, Sewerin S, et al.: Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes. Genet Med 22: 1374–1383, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84

    Mason AE, Sen ES, Bierzynska A, Colby E, Afzal M, Dorval G, et al.; UK RaDaR/NephroS Study: Response to first course of intensified immunosuppression in genetically stratified steroid resistant nephrotic syndrome. Clin J Am Soc Nephrol 15: 983–994, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85

    Howles SA, Thakker RV: Genetics of kidney stone disease. Nat Rev Urol 17: 407–421, 2020 PubMed

  • 86

    Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O’Riordan WD, Cochat P, et al.; ILLUMINATE-A Collaborators: Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N Engl J Med 384: 1216–1226, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 1032 146 6
Full Text Views 1278 133 6
PDF Downloads 1612 183 10